We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microscopy Innovation Developed to Diagnose Cancer

By LabMedica International staff writers
Posted on 23 May 2017
Researchers have developed a spectrophotometric technique for microscopic analysis of variations in single cancer cells, enabling more efficient diagnosis of melanomas, including metastasize forms.

For years, melanoma researchers have studied samples that were considered uniform in size and color. More...
But melanomas don’t always come in the same shape and hue; often, melanomas are irregular and dark, making them difficult to investigate.

“Researchers often seek out the types of cancerous cells that are homogenous in nature and are easier to observe with traditional microscopic devices,” said study first author Luis Polo-Parada, associate professor at University of Missouri, “Yet, because the vast amount of research is conducted on one type of cell, it often can lead to misdiagnosis in a clinical setting.”

In their new study, including researchers in Mexico as part of UM’s “Mizzou Advantage” program to foster interdisciplinary collaboration, the team devised a tool to detect and analyze single melanoma cells that are more representative of the skin cancers developed by most patients. They decided to supplement the emerging technique photoacoustic (PA) spectroscopy, a specialized optical technique used to probe tissues and cells non-invasively. Ellison Gordon of UM’s machine shop was involved in the manufacturing of components for the microscope setup.

Current systems use the formation of sound waves followed by the absorption of light, so the tissues must adequately absorb the laser light. This is why most researchers have focused only on consistently hued and shaped melanoma cells. The team modified a microscope that was able to merge light sources at a range conducive to observing the details of single melanoma cells. Using the modified system, they could identify irregularities in human melanoma and breast cancers as well as mouse melanoma cells, enabling them to reach a diagnosis with greater ease and efficiency. The team also noted that as the cancer cells divided, they grew paler in color yet the system was able to detect the newer, smaller cells as well.

“Overall, our studies show that by using modified techniques we will be able to observe non-uniform cancer cells, regardless of their origin,” Prof. Polo-Parada said, “Additionally, as these melanoma cells divide and distribute themselves throughout the blood, they can cause melanomas to metastasize. We were able to observe those cancers as well. This method could help medical doctors and pathologists to detect cancers as they spread, becoming one of the tools in the fight against this fatal disease.”

The study, by Polo-Parada L et al, was published March 13, 2017, in the journal Analyst.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Three presentations will examine Arima Genomics’ high-throughput Hi-C sequencing technology in salivary gland cancer, triple-negative breast cancer, and aggressive cutaneous T-cell lymphoma (Photo courtesy of Arima Genomics)

New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma

Arima Genomics (Carlsbad, CA, USA) will present new research highlighting the expanding clinical applications of its Aventa FusionPlus and Aventa Lymphoma tests at the Association for Molecular Pathology... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: The multiplex molecular panels assess 22 and 11 targets, respectively, spanning bacteria, viruses, and parasites from a single stool sample, with results available in approximately one hour (Photo courtesy of bioMérieux)

Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing

Acute infectious gastroenteritis, caused by viral, bacterial, and parasitic pathogens, remains a significant global health concern that inflames the gastrointestinal tract. Symptoms such as diarrhea, vomiting,... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.